Antibodies and other biomarkers - pathological consequences (2).
Ehrenstein
M R
MR
Centre for Rheumatology Research, Windeyer Institute of Medical Science, University College London, London, UK. m.ehrenstein@ucl.ac.uk
Alves
J D
JD
D000818:Animals; D001323:Autoantibodies / Q000633:toxicity*; D001402:B-Lymphocytes / Q000502:physiology; D015415:Biomarkers; D058851:GPI-Linked Proteins; D020022:Genetic Predisposition to Disease; D006801:Humans; D008075:Lipoproteins, HDL / Q000276:immunology; D008180:Lupus Erythematosus, Systemic / Q000209:etiology* / Q000235:genetics / Q000276:immunology; D017452:Receptors, IgG / Q000235:genetics
D001323:Autoantibodies; D015415:Biomarkers; C428200:FCGR3B protein, human; D058851:GPI-Linked Proteins; D008075:Lipoproteins, HDL; D017452:Receptors, IgG